AEterna Zentaris Inc. (USA)


Maxim Weighs In On AEterna Zentaris Inc. (USA) (AEZS) As Zoptrex Completes Enrollment

Shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) jumped over 20% today, after the drug maker announced the completion of the clinical phase of …

Stock Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA) Announces Completion of Zoptrex Pivotal Phase 3 Clinical Trial in Advanced Endometrial Cancer

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) announced the occurrence of the 384th death in the pivotal Phase 3 ZoptEC (Zoptarelin Doxorubicin in Endometrial Cancer) …

Maxim Boosts Price Target for AEterna Zentaris Inc. (USA) (AEZS); Shares Rose 11%

Maxim analyst Jason Kolbert is out with a bullish research report today on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) just one week after the …

Canaccord Cuts Price Tag on AEterna Zentaris Inc. (USA) (AEZS) Following Doomed Macrilen Phase 3 Failure; Shares Fall 8%

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) shares are sinking 8% after the firm announced what Canaccord analyst Neil Maruoka deems “another disappointment for Macrilen,” …

H.C. Wainwright Weighs in on AEterna Zentaris Inc. (USA) (AEZS) Post Q3 Update

On November 9th, AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) posted third-quarter financial earnings and held a conference call.

Maxim Bullish on AEterna Zentaris Inc. (USA) (AEZS) After 3Q Results

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) shares are jumping nearly 5% after the biotech firm posted third-quarter results yesterday that with a pivotal clinical …

Company Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA) Reports 3Q:16 Financial and Operating Results

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) reported financial and operating results for the third quarter ended September 30, 2016.

Company Update (NASDAQ:AEZS): Here’s Why AEterna Zentaris Inc. (USA) Shares Are Tumbling 10% Today

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) announced that it intends to raise $7,560,000 in gross proceeds in a registered direct offering to a single healthcare …

Company Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA) Completes Patient Recruitment for Confirmatory Phase 3 Trial of Macrilen

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) announced it has successfully completed patient recruitment for the confirmatory Phase 3 clinical trial of Macrilen™ (macimorelin) as a …

Stock Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA) and STA Sign Exclusive License Agreement for the Potential Marketing of Zoptrex™ in Australia and New Zealand

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) and Specialised Therapeutics Asia (STA) announced the signing of an exclusive license agreement for the Company’s lead investigational anti-cancer …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts